CompletedPhase 2NCT01161628

Rituximab for the Primary Treatment of Denovo Extensive Chronic Graft Versus Host Disease (GVHD)

Studying Bronchiolitis obliterans

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Northside Hospital, Inc.
Principal Investigator
Scott R Solomon, MD
Blood and Marrow Transplant Group of Georgia
Intervention
Rituximab(drug)
Enrollment
25 enrolled
Eligibility
18-75 years · All sexes
Timeline
20112015

Study locations (1)

Collaborators

Blood and Marrow Transplant Group of Georgia

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01161628 on ClinicalTrials.gov

Other trials for Bronchiolitis obliterans

Additional recruiting or active studies for the same condition.

See all trials for Bronchiolitis obliterans

← Back to all trials